The value of SARS-CoV-2 serology testing and the role of neutralization

Serology assays can be used for discerning seroprevalence, screening volunteers for vaccine trials and convalescent plasma donations, as well as predicting infection or vaccine-induced immunity.

Several commercially available SARS-CoV-2 immunoassays have been evaluated for their sensitivity and further studies have evaluated the role of the antigen target in its ability to assess protection against reinfection. Public health strategies going forward will be based on the ability to answer a) how circulating antibody levels that are specific for each viral antigen change with time following natural infection and b) which serological assays best predict protective immunity.

In this webinar, Dr. Sara Jenks, consultant biochemist, will demonstrate the value of serology in managing COVID-19.

Key learning objectives:

• Understand the role serology plays in the clinician toolbox for managing COVID-19
• Know the difference between the neutralization capabilities of assays that target the nucleocapsid versus the spike protein
• Learn the importance of long-term kinetics of antibody titers and the corresponding effectiveness of commercial assays in correctly interpreting testing protocols

Attendees of this webinar are entitled to P.A.C.E. credits from the ASCLS and/or ACCENT credits from the AACC.

This webinar will run on Monday, October 26, at:

• 16:00 GMT
• 17:00 CET
• 12:00 EDT
• 09:00 PDT

Register for this webinar here>>

SelectScience runs more than 10 webinars a month across various scientific topics, discover more of our webinars here>>